We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
Cap. Flow
+$1.35B
Cap. Flow %
3.15%
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$21.8M
2
CVX icon
Chevron
CVX
+$20.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$19.7M
4
INCY icon
Incyte
INCY
+$17.8M
5
XOM icon
ExxonMobil
XOM
+$16.9M

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Technology 15.06%
3 Healthcare 13.05%
4 Industrials 10.88%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRE
2701
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$164K ﹤0.01%
66,008
JAX
2702
DELISTED
J. Alexander's Holdings, Inc.
JAX
$163K ﹤0.01%
16,224
+627
+4% +$6.1K
PLPM
2703
DELISTED
Planet Payment, Inc
PLPM
$163K ﹤0.01%
41,075
+1,980
+5% +$8.15K
SMRT
2704
DELISTED
Stein Mart Inc
SMRT
$162K ﹤0.01%
53,671
+9,998
+23% +$35.4K
NERV icon
2705
Minerva Neurosciences
NERV
$187M
$161K ﹤0.01%
2,492
+99
+4% +$7.69K
RLGT icon
2706
Radiant Logistics
RLGT
$388M
$161K ﹤0.01%
32,297
+1,574
+5% +$7.25K
TPHS
2707
DELISTED
Trinity Place Holdings Inc.com
TPHS
$159K ﹤0.01%
21,816
+3,060
+16% +$24.7K
OSG
2708
DELISTED
Overseas Shipholding Group Inc.
OSG
$159K ﹤0.01%
41,269
+1,558
+4% +$7.35K
VYGR icon
2709
Voyager Therapeutics
VYGR
$189M
$158K ﹤0.01%
11,947
+499
+4% +$6.05K
CSLT
2710
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$156K ﹤0.01%
42,734
+1,891
+5% +$6.64K
AFH
2711
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$156K ﹤0.01%
11,447
+575
+5% +$8.87K
RNWK
2712
DELISTED
RealNetworks Inc
RNWK
$156K ﹤0.01%
32,266
-2,654
-8% -$13.1K
MR
2713
DELISTED
Montage Resources Corporation Common Stock
MR
$155K ﹤0.01%
4,073
+178
+5% +$6.48K
GIFI
2714
DELISTED
Gulf Island Fabrication
GIFI
$153K ﹤0.01%
+13,225
New +$163K
PDSB icon
2715
PDS Biotechnology
PDSB
$39.1M
$153K ﹤0.01%
838
+38
+5% +$7.53K
JONE
2716
DELISTED
Jones Energy, Inc.
JONE
$153K ﹤0.01%
3,008
+145
+5% +$10.3K
ULH icon
2717
Universal Logistics Holdings
ULH
$353M
$151K ﹤0.01%
10,509
+392
+4% +$5.53K
SYUT
2718
DELISTED
Synutra International, Inc.
SYUT
$151K ﹤0.01%
25,319
+990
+4% +$5.68K
TRAK icon
2719
ReposiTrak
TRAK
$157M
$150K ﹤0.01%
12,140
+608
+5% +$8.37K
HIL
2720
DELISTED
Hill International, Inc. Common Stock
HIL
$149K ﹤0.01%
35,987
+1,384
+4% +$6.88K
CBMG
2721
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$149K ﹤0.01%
12,601
+568
+5% +$6.9K
VCYT icon
2722
Veracyte
VCYT
$4.77B
$147K ﹤0.01%
16,047
+1,799
+13% +$14.7K
GDEN
2723
DELISTED
Golden Entertainment
GDEN
$146K ﹤0.01%
11,045
+480
+5% +$5.77K
NAGE
2724
Niagen Bioscience
NAGE
$264M
$143K ﹤0.01%
53,053
+30,739
+138% +$87.2K
I
2725
DELISTED
INTELSAT S. A.
I
$143K ﹤0.01%
34,427
+1,480
+4% +$5.58K

Similar funds

RhumbLine Advisers's Q1 2017 Portfolio in Review

As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.

  • RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
  • RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
  • RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
  • RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
  • RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
  • RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.

Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.